You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中新藥業(600329.SH):津滬深公司為控股股東醫藥集團混改項目的最終受讓方
格隆匯 12-20 20:32

格隆匯 12 月 20日丨中新藥業(600329.SH)公佈,公司於2020年12月20日收到控股股東天津市醫藥集團有限公司(以下簡稱"醫藥集團")關於醫藥集團混合所有制改革進展的通知。截至公告披露日,醫藥集團持有公司42.80%股權。

2020年12月20日,醫藥集團收到控股股東天津渤海國有資產經營管理有限公司(以下簡稱"渤海國資")的通知:在醫藥集團67%股權公開掛牌轉讓項目中,截至天津產權交易中心掛牌結束,津滬深生物醫藥科技有限公司(以下簡稱"津滬深公司")為唯一摘牌方,津滬深公司為醫藥集團混改項目的最終受讓方。

2020年12月19日,渤海國資和津滬深公司簽署了《產權交易合同》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account